Difference between revisions of "Template:Glycine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 35: | Line 35: | ||
* [[Taurine]] | * [[Taurine]] | ||
| − | * '''Positive modulators:''' [[Alcohol]]s (e.g., [[brometone]], [[chlorobutanol|chlorobutanol (chloretone)]], [[ethanol]], [[tert-Butyl alcohol|''tert''-butanol (2M2P)]], [[tribromoethanol]], [[trichloroethanol]], [[trifluoroethanol]]) | + | * '''Positive modulators:''' [[Alcohol]]s (e.g., [[brometone]], [[chlorobutanol|chlorobutanol (chloretone)]], [[alcohol (drug)|ethanol (alcohol)]], [[tert-Butyl alcohol|''tert''-butanol (2M2P)]], [[tribromoethanol]], [[trichloroethanol]], [[trifluoroethanol]]) |
* [[Alkylbenzene sulfonate]] | * [[Alkylbenzene sulfonate]] | ||
* [[Anandamide]] | * [[Anandamide]] | ||
| Line 104: | Line 104: | ||
* [[Imipramine]] | * [[Imipramine]] | ||
* [[NBQX]] | * [[NBQX]] | ||
| − | * [[Neuroactive steroid]]s (e.g., [[3α-androsterone sulfate]], [[3β-androsterone sulfate]], [[deoxycorticosterone]], [[DHEA sulfate]], [[pregnenolone sulfate]], [[progesterone]]) | + | * [[Neuroactive steroid]]s (e.g., [[3α-androsterone sulfate]], [[3β-androsterone sulfate]], [[11-deoxycorticosterone|deoxycorticosterone]], [[DHEA sulfate]], [[pregnenolone sulfate]], [[progesterone]]) |
* [[Opioid]]s (e.g., [[codeine]], [[dextromethorphan]], [[dextrorphan]], [[levomethadone]], [[levorphanol]], [[morphine]], [[oripavine]], [[pethidine]], [[thebaine]]) | * [[Opioid]]s (e.g., [[codeine]], [[dextromethorphan]], [[dextrorphan]], [[levomethadone]], [[levorphanol]], [[morphine]], [[oripavine]], [[pethidine]], [[thebaine]]) | ||
* [[Picrotoxin]] (i.e., [[picrotin]] and [[picrotoxinin]]) | * [[Picrotoxin]] (i.e., [[picrotin]] and [[picrotoxinin]]) | ||
| Line 131: | Line 131: | ||
* [[AMG-747]] | * [[AMG-747]] | ||
* [[ASP2535]] | * [[ASP2535]] | ||
| + | * [[BIIB-104|BIIB-104 (PF-04958242)]] | ||
* [[Bitopertin|Bitopertin (RG1678/RO4917838)]] | * [[Bitopertin|Bitopertin (RG1678/RO4917838)]] | ||
* [[CP-802079]] | * [[CP-802079]] | ||
| − | * [[Ethanol]] | + | * [[Alcohol (drug)|Ethanol (alcohol)]] |
* [[Glycyldodecylamide]] | * [[Glycyldodecylamide]] | ||
* [[GSK1018921]] | * [[GSK1018921]] | ||
* [[LY-2365109]] | * [[LY-2365109]] | ||
| − | |||
* [[ORG-24598]] | * [[ORG-24598]] | ||
* [[ORG-25935|ORG-25935 (SCH-900435)]] | * [[ORG-25935|ORG-25935 (SCH-900435)]] | ||
* [[PF-02545920]] | * [[PF-02545920]] | ||
* [[PF-03463275]] | * [[PF-03463275]] | ||
| − | |||
* [[Sarcosine]] | * [[Sarcosine]] | ||
* [[SSR-103,800]] | * [[SSR-103,800]] | ||
| Line 150: | Line 149: | ||
| list2 = | | list2 = | ||
* [[Amoxapine]] | * [[Amoxapine]] | ||
| − | * [[Ethanol]] | + | * [[Alcohol (drug)|Ethanol (alcohol)]] |
* [[N-Arachidonylglycine|NAGly]] | * [[N-Arachidonylglycine|NAGly]] | ||
| − | * [[ | + | * [[Opiranserin|Opiranserin (VVZ-149)]] |
| + | * [[ORG-25543]] | ||
| + | * [[VVZ-368]] | ||
<!-- | group3 = [[Vesicular inhibitory amino acid transporter|VIAAT]] | <!-- | group3 = [[Vesicular inhibitory amino acid transporter|VIAAT]] | ||
| Line 187: | Line 188: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 17:35, 1 August 2018
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Glycine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Glycine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Glycine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.